Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer.
about
Stereotactic radiotherapy for early lung cancer: Evidence-based approach and future directionsNormal tissue toxicity after small field hypofractionated stereotactic body radiation.Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancerRetrospective analysis of stereotactic ablative radiotherapy (SABR) for metastatic lung lesions (MLLs) in comparison with a contemporaneous cohort of primary lung lesions (PLLs)Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: pilot study resultsImaging characteristics of local recurrences after stereotactic body radiation therapy for stage I non-small cell lung cancer: Evaluation of mass-like fibrosis.Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapyLungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspectiveLungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.The use of isodose levels to interpret radiation induced lung injury: a quantitative analysis of computed tomography changesSalvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer.New techniques for assessing response after hypofractionated radiotherapy for lung cancerThe role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient?Imaging changes after stereotactic body radiation therapy for lung and liver tumors.Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria.2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies.Dosimetric analysis of imaging changes following pulmonary stereotactic body radiation therapy.Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy.Pros: After stereotactic ablative radiotherapy for a peripheral early-stage non-small cell lung cancer, radiological suspicion of a local recurrence can be sufficient indication to proceed to salvage therapyDifferentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes.Cons: After lung stereotactic ablative radiotherapy for a peripheral stage I non-small cell lung carcinoma, radiological suspicion of a local recurrence is not sufficient indication to proceed to salvage therapy.The oligometastatic state - separating truth from wishful thinking.Radiological differential diagnosis between fibrosis and recurrence after stereotactic body radiation therapy (SBRT) in early stage non-small cell lung cancer (NSCLC).Stereotactic body radiotherapy for stage I non-small cell lung cancer.Early PET-CT After Stereotactic Radiotherapy for Stage 1 Non-small Cell Lung Carcinoma Is Predictive of Local Control.A new approach to quantifying lung damage after stereotactic body radiation therapy.Lung density change after SABR: A comparative study between tri-Co-60 magnetic resonance-guided system and linear accelerator.The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis.CT perfusion imaging in response assessment of pulmonary metastases undergoing stereotactic ablative radiotherapy.Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer.FoxM1-dependent RAD51 and BRCA2 signaling protects idiopathic pulmonary fibrosis fibroblasts from radiation-induced cell death.[Radiation pneumonitis after stereotactic body radiation therapy for early stage non-small cell lung cancer].Nebulisation of synthetic lamellar lipids mitigates radiation-induced lung injury in a large animal model
P2860
Q28085744-68FAB0C5-6CEC-45DB-951B-44A2F657066DQ30484881-08C35BEA-6CB8-4591-BBF8-6061F23A7C6BQ30857091-CF14C188-DA58-45F6-A9BE-212B564BFFE4Q33571109-4C1AD048-51DC-4C12-A52A-D2744A6DAAB4Q34734585-4DAB41A3-60FE-4348-91B0-E4E9065C7F8FQ35663626-6A5372A3-76CD-4897-AAE1-3D9263544935Q35990998-600701CC-13C8-476B-9C78-592947145911Q36235727-5E05BCAA-73AB-43F8-9897-8177D21DE22CQ36485777-236AAE27-E605-4DF1-BBAE-9DCEFB7C611EQ36642258-25122501-9686-4589-93CD-64FA281046BEQ37307675-3C21A80C-ADDF-4B1A-A369-40C76462B2B0Q37670432-969B7D4E-F16F-4876-811F-5A8178BB4236Q37743289-88C164DB-6B92-4BFF-AD2D-0C3400684A94Q37866792-98827F47-8424-4A13-9A2E-417022E5CE05Q37942070-BE9A8EE3-0C10-4945-A9D1-F67D3B85DA63Q38190426-8699D3B3-96C9-4ABD-8973-5B77771C7BE4Q38849150-981D76F5-13A8-4823-93E7-DCDAE0CBC140Q38871523-AEA45591-EE7A-4776-A645-9F5A682A405DQ39774605-B121CE3B-2637-49A0-86C4-9C4CDE43AB42Q41856048-01E23006-A0E2-4C90-9E30-A45CF929194DQ42330755-99F8D6A7-47B7-404C-B236-6B0DE9994975Q45070442-23D2E59F-4042-4ECF-A613-4F24C351F543Q45729506-52EBB955-3A8C-449A-BCBD-FFACAC8513C2Q46037366-A61587BE-D3B7-4A80-B7D7-ACE4E41C7E25Q46288612-DDF28FA8-ACEE-442D-BCF9-B1618DCFDEC9Q47095312-A9759B42-6E7B-4C91-995B-1088D7081D1CQ49356651-E453F389-B4DE-49F5-98C3-0A4AA30CB2D3Q49594040-55C52103-7A69-44AE-B62E-FD9C4525A253Q51622512-310AB241-51B6-4A0F-BE7E-91CF8A53F04BQ52613276-1C96A071-24C9-45AA-9FE7-A1EF533DA26EQ52727884-DA7E3FB7-4115-4D34-A9D9-662844F7E33BQ53030132-C292FF70-5CA6-4B80-BD40-86B94C93FB17Q53076710-408CFD2D-E4A6-4987-BF50-0B0FBF99398CQ54943861-675CCA21-FDC9-4300-8CF8-ACAEE85A3C65Q55441727-5B6A6475-E86A-48A3-A904-58642415D9D5Q58761891-A9CCA154-6D78-4339-BE6A-18AC437A1B1F
P2860
Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Possible misinterpretation of ...... radiotherapy for lung cancer.
@en
type
label
Possible misinterpretation of ...... radiotherapy for lung cancer.
@en
prefLabel
Possible misinterpretation of ...... radiotherapy for lung cancer.
@en
P2093
P1476
Possible misinterpretation of ...... radiotherapy for lung cancer.
@en
P2093
Atsushi Kubo
Atsuya Takeda
Etsuo Kunieda
Hirofumi Fujii
Michio Tanaka
Naoyuki Shigematsu
Toshiaki Takeda
P304
P356
10.1016/J.IJROBP.2007.07.2383
P407
P50
P577
2007-10-01T00:00:00Z